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Abstract: Respiratory syncytial virus (RSV) is one of the most important pathogen causing severe lower respiratory  
tract infections in all age groups often requiring hospitalization. Rapid laboratory diagnosis of RSV infection significantly 
decreases the use of antibiotics, additional laboratory testing and is associated with shorter hospitalization periods.   
The specific diagnosis of RSV infection is based on the detection of virus or viral antigens or virus specific nucleic acid 
sequences in respiratory secretions. The kind and quality of the clinical specimen exerts a considerable influence on the 
results of all currently used viral detection assays. Antigen based tests are widely available, easy to perform and the results 
are available in a short time but their reduced sensitivity and specificity represent a considerable shortcoming. Among  
the methods available isolation in cell culture was considered the gold standard for the sensitive identification of RSV but 
is gradually replaced by highly sensitive and specific nucleic acid amplification assays that provide more rapid results. Of 
these reverse transcription polymerase chain reaction (PCR) was the first and is still the most frequently used nucleic acid- 
based assay. New methodologies, as for example the real-time PCR methods allow the quantification of viral nucleic acids 
in the clinical sample. Disadvantages of the nucleic acid based assays are their high costs and their limited standardization. 
Future research on new methodologies for the diagnosis of viral respiratory tract infections should focus on the develop-
ment of sensitive, rapid and cost effective test systems allowing the screening for all probable causative agents. In   
addition varying testing protocols for summer and winter months based on epidemiologic data are needed to direct their 
practical use.  
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INTRODUCTION 
  Respiratory syncytial virus (RSV) is one of the most im-
portant respiratory pathogens, causing severe infections of 
the lower respiratory tract in infants, small children, the eld-
erly, and in immunosuppressed patients, often requiring hos-
pitalization [1-7]. RSV is highly contagious and gives rise to 
yearly epidemic outbreaks of respiratory tract infections dur-
ing the late fall, winter and early spring with only sporadic 
cases detected year round [1, 8-10] (Fig. 1).  
  Almost all children have serologic evidence of RSV in-
fection by 2 years of age. Primary RSV infection is rarely 
asymptomatic and the peak period of serious illness due to 
RSV is during the first few months of life with average an-
nual hospitalization rates of 17 per 1000 children under 6 
months of age and 3 per 1000 children under 5 years of age 
[12]. Underlying conditions, most frequently premature birth 
or cardiopulmonary disease are additional risk factors for 
severe RSV disease requiring hospitalization [13, 14]. In 
addition, previous RSV infections do not confer protection 
and reinfections throughout life are very common [15, 16]. 
Despite an increasing number of newly identified respiratory  
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viruses, RSV remains the most important etiologic agent in 
infants below two years of age hospitalized with acute respi-
ratory tract infection (Fig. 2). 
  Due to the high number of potential pathogens that may 
cause similar symptoms of respiratory illness, clinical char-
acteristics are rarely distinctive enough to accurately dis-
criminate RSV-related from other, non-RSV-related respira-
tory tract infections [18, 19]. Laboratory confirmation of 
clinically suspected RSV infection generally depends on the 
detection of the virus in respiratory secretions of the patient. 
Immunofluorescent staining of viral antigens in respiratory 
epithelial cells, introduced by Philipp Gardner in the 1970ies 
[20, 21] was the first specific rapid diagnostic test. Since 
then rapid, sensitive and specific diagnostic tools have been 
developed and their increasing availability and use unveiled 
the prominent role of RSV in lower respiratory tract infec-
tion in childhood and the strong association of RSV bron-
chiolitis in infancy and wheezing in later childhood [22-24]. 
The following article will provide a short review on the di-
agnostic value, the advantages and limitations of the most 
currently used techniques for RSV diagnosis.  
Clinical Manifestations 
  RSV infection is associated with a variety of clinical 
manifestations ranging from mild cold-like symptoms to 
severe lower respiratory tract illness with significant wheez-
ing, breathing difficulty, cyanosis and possibly apnoeic epi-Diagnosis of Respiratory Syncytial Virus Infection  The Open Microbiology Journal, 2011, Volume 5    129 
sodes. Between 25% and 40% of children develop symptoms 
of bronchiolitis or pneumonia during their primary RSV in-
fection [25-28]. In addition to the more common symptoms 
of lower respiratory tract infection a variety of extrapulmon-
ary manifestations, ranging from cardiac involvement to   
sepsis-like syndrome have been observed in children with 
severe RSV disease [29, 30], but whether they represent   
direct or indirect effects of the virus is unclear. In premature 
infants RSV infection is frequently atypical in its clinical 
presentation and may manifest as apnoea, bradycardia, or 
changes in feeding and ventilation [13, 31].  
Reasons for RSV Testing 
  Rapid laboratory confirmation of RSV infection results in 
a reduced number of ancillary tests, a decrease in antibiotic 
use and shorter hospitalization periods in clinical paediatric 
practice [32, 33]. Laboratory diagnosis is also required for 
children with atypical clinical presentations, such as respira-
tory distress or sepsis like syndrome and in premature infants 
with non-specific signs in order to rule out another cause and 
to avoid delayed diagnosis. As RSV is highly contagious, 
rapid identification of RSV infected infants in hospital wards 
is of utmost importance in order to initiate appropriate infec-
tion control precautions to prevent nosocomial outbreaks [4, 
13, 34]. Viral testing using rapid and sensitive assays for the 
detection of RSV are also required to take the offensive for 
preventive programs and to assess the efficacy of antiviral 
prophylaxis [35, 36]. Other reasons for viral testing exist, 
such as for research and epidemiologic monitoring of RSV 
activity. 
Laboratory Diagnosis 
  The specific diagnosis of RSV infection is made by the 
detection of the virus or viral antigens or virus specific nu-
cleic acid sequences in respiratory secretions. The kind and 
quality of the clinical specimen exerts a considerable influ-
ence on the sensitivity and specificity of all viral detection 
assays currently available. It has been demonstrated that a 
nasal wash or a nasopharyngeal aspirate is more sensitive for 
the detection of RSV than a nasopharyngeal swab specimen 
[37, 38]. However the collection of a nasopharyngeal swab is 
far less unpleasant for the patient, does not require special-
ized equipment, and can also be performed in an out-patient 
setting. Using the recently designed flocked-nasopharyngeal-
swabs, which effectively dislodge and collect virus infected 
cells lining the nasopharynx greatly improves the quality of 
 
 
 
 
 
 
 
 
 
Fig. (1). Seasonality of respiratory syncytial virus (RSV) in Austria from 2000 to 2007 (top panel). The weeks of onset and offset of RSV activ-
ity (bottom panel) are defined as the first of two consecutive cases when > 10% of respiratory secretions test positive by PCR and the last week 
of > 10% positive tests preceding 2 consecutive weeks of < 10% positive tests, as described in the annual report NREVSS 2005 [11].  
 
 
 
 
 
 
 
Fig. (2). Detection of respiratory viruses in NPAs obtained from 772 infants hospitalized with acute respiratory tract illness from October 
2000 through July 2004 [17]. 
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swab specimens and significantly increases the diagnostic 
yield of this clinical specimen [39-42]. 
  Laboratory methods currently available for the detection 
of RSV include virus isolation in tissue culture, detection of 
viral antigens by direct or indirect immunofluorescent (IF) 
staining (DFA/IFA) or by enzyme-linked immunosorbent 
assays (EIAs) and the detection of viral nucleic acids by   
amplification assays, predominantly reverse transcription 
polymerase chain reaction (RT-PCR). 
Virus Isolation in Tissue Culture  
  Isolation of RSV in tissue culture was considered as the 
gold standard for confirmation of presumed RSV infection 
for quite a long period of time. However besides the techni-
cal expertise in appropriate specimen handling for efficient 
virus recovery, this technique requires an average of 3 to 6 
days until syncytial cytopathic effect appears. Shell vial cen-
trifugation cultures followed by DFA or immunoperoxidase 
staining using virus specific monoclonal antibodies signifi-
cantly increases the sensitivity of the tissue culture technique 
and shortens the turnaround time for virus identification to 1 
to 2 days [43-45]. 
  The advantage of the tissue culture technique is that it  
is more sensitive than rapid antigen detection kits and that  
it provides the ability of further antigenic and genetic   
characterization of the amplified virus which can be used for 
the screening of epidemiological relevant mutations or for 
the confirmation of nosocomial transmission by sequence 
analysis [46-48].  
Antigen Detection 
  Antigen detection assays include direct immunofluores-
cence assays (DFA), enzyme immunosorbent assays (EIA), 
chromatographic and optical immunoassays [49-54]. The 
DFA uses fluorescein-labelled antibodies that detect RSV 
antigen in epithelial cells in respiratory secretions and has 
the advantage that the immunofluorescence pattern of the 
infected cells can be directly examined by microscopy which 
provides additional confirmation of specificity. In the EIA, 
RSV antigen, if present, is captured by RSV-specific anti-
bodies and will be detected by a second enzyme-linked anti-
body. Antigen detection kits are easy to perform and the re-
sults are available in a short time. For these reasons they are 
widely used in clinical practice. Currently available antigen 
detection kits in paediatric specimens have sensitivities of 72 
to 94% and specificities of 95 to 100% as compared to cell 
culture (Table 1). However, in older children and adults, 
detection rates for EIA are extremely low with sensitivities 
of 0 to 20% (Tables 1 and 2), most likely because of the sub-
stantially lower viral titre and shorter virus shedding in a 
group of patients experiencing RSV reinfections [55]. The 
Table 1.  Evaluation of RSV Rapid Antigen Detection Tests in Respiratory Specimens Obtained from Children and Adults with 
RSV Infection Confirmed by Cell Culture  
Assays  % Sensitivity  % Specificity  Positive Predictive Value  Negative Predictive Value 
  Children 
n=108 
Adults 
n=41 
Children 
n=127 
Adults 
n=53 
Children 
n=84 
Adults 
n=34 
Children 
n=66 
Adults 
n=22 
DFA  93 100 97  97  95  80  96 100 
BD Directigen  81 25 95 98 90 50 91 94 
BD Directigen EZ  72 0 98  100  93    90  82 
Binax Now  94 0  100  100  100   96  94 
DFA, direct immunofluorescence assay (Merifluor RSV identification reagent, Meridian Bioscience Inc., Cincinnati, Ohio); BD Directigen, direct enzyme immunoassay and BD 
Directigen EZ (Becton Dickinson, Cockeysville, MD); Binax Now, rapid immunoassay (Binax, Inc., Portland, Maine), modified from [50]. 
 
Table 2.  Evaluation of RSV Rapid Antigen Detection Tests in Respiratory Specimens Obtained from Adults with RSV Infection 
Confirmed by Cell Culture and/or Serology and/or RT-PCR 
Assays  n Positive out of 60  
Confirmed Infections 
% Sensitivity  % Specificity  Positive Predictive 
Value 
Negative Predictive 
Value 
Cell culture  28   46  100  100  95 
RT-PCR  49   82  100  100  98 
DFA  14   23  97  44  93 
VIDAS  12   20  97  40  92 
BD Directigen  6   10  97  25  92 
DFA, direct immunofluorescence assay (Bartels (Bartels, Inc., Issaquah, WA); VIDAS, automated enzyme immunoassay (BioMerieux, Inc., Hazelwood, MI); Directigen, direct 
enzyme immunoassay (Becton Dickinson, Cockeysville, MD), modified from [58]. Diagnosis of Respiratory Syncytial Virus Infection  The Open Microbiology Journal, 2011, Volume 5    131 
specificity of antigen detection kits may be significantly re-
duced, especially if used outside the epidemic periods, when 
the prevalence of the virus in the community is low and the 
rate of false positive results becomes relatively high [56-60]. 
Although numerous efforts are undertaken to improve the 
sensitivity and specificity of antigen detection kits, methods 
are less specific and far
  less sensitive than nucleic acid   
amplification assays [61-63]. 
Nucleic Acid Tests (NATs) 
  Nucleic acid assays have revolutionized the diagnostic 
procedures in virology and are the most sensitive and spe-
cific methods for the detection of RSV, regardless of the 
patient population tested [58, 64-69]. Studies comparing 
molecular diagnostic assays to virus isolation in cell culture 
and to antigen detection assays have demonstrated superior 
sensitivity for nucleic acid tests [62, 63, 70-73] (Table 2) 
which leads to an approximately twofold increase of detec-
tion rates in infants with respiratory illness [71, 74]. Young 
children experiencing primary infection usually shed large 
quantities of RSV over a prolonged period of time. With the 
increasing number of subsequent infections, virus is shed in 
lower quantities for shorter times [75] due to the presence of 
secretory and humoral virus-specific antibodies influencing 
the degree of viral replication [76]. Therefore a decrease in 
the efficacy of RSV detection with increasing age of the pa-
tient has been reported in various studies [50, 56, 57, 70, 77-79]. 
Nevertheless molecular diagnostic assays are definitely also 
more sensitive for older age groups as a result of the lower 
virus production in these patients (Table 2, Fig. 3). 
  Of the different nucleic acid amplification techniques, 
reverse transcription polymerase chain reaction (RT-PCR) 
was the first and most frequently used nucleic acid-based 
assay [80-82]. In the last ten years, numerous in-house PCR 
protocols have been published for amplifying various gene 
segments of the RSV genome [70, 83-87] and, in addition, 
an increasing number of commercial RSV NAT kits are now 
available.  
  New PCR techniques, as for example the real-time PCR 
methods, have been developed. Real-time PCR assays that 
use fluorescent probes such as Taqman, molecular beacons 
and scorpion probes enable the simultaneous performance of 
amplification and detection and result in a considerable in-
crease in the speed of RT-PCR with a turnaround time of a 
few hours. Protocols have also been designed for simultane-
ous amplification of RSV together with various other respi-
ratory viruses which cause similar clinical symptoms. These 
multiplex PCR assays are able to identify a variety of differ-
ent respiratory viruses simultaneously, either within a single 
tube or by parallel detection in a single PCR run. Using 
highly sensitive monoplex or multiplex PCR assays, it turned 
out that a significant proportion of up to 10-30% of respira-
tory illness cases and up to 50% of RSV-infections in infants 
represent mixed infections of 2 or more respiratory viruses 
[17, 24, 74, 88-90] (Fig. 2). The impact of a coinfection on 
the clinical course of illness still remains controversial. A 
significantly increased risk of more severe disease or of ad-
mission to a paediatric intensive care unit has been reported 
for dual as compared to single respiratory virus detection by 
some [91-93], but not by other studies [17, 74]. 
  An important benefit of real-time PCR is that it allows 
quantification of viral nucleic acids present in a sample [66, 
77]. The diagnostic value of the determination of viral loads 
in respiratory tract infections is still unclear, because respira-
tory specimens are difficult to standardize, especially with 
regard to the amount of virus or virus-infected cells within 
specimens and the non-standardized dilution of samples.  
  As far as RSV is concerned higher viral loads seem to 
correspond with a more severe clinical course of the disease 
[94, 95] and an increased likelihood of recurrence of wheez-
ing [24]. In patients in whom multiple viruses are detected 
quantitative RT-PCR may help to discriminate between the 
virus actually causing the acute respiratory disease and those 
simultaneously detected but without a causative relationship 
to the actual clinical symptoms.  
Determination of RSV-Specific Antibodies (Serology) 
  Testing for virus specific antibodies is not useful for the 
diagnosis of acute RSV-infection. A serologic response is 
usually not detectable in infants, despite severe RSV infec-
 
 
 
 
 
 
 
 
 
Fig. (3). Detection of Respiratory Syncytial Virus in NPAs by semi-nested RT-PCR, Ag-ELISA and Virus isolation with regard to the  
patient’s age [70].  
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tion [75, 96]. Even when sophisticated tests for the detection 
of class specific antibodies are used, the infant’s own anti-
body response is barely detectable in the presence of mater-
nally derived antibodies [97] and even in older children and 
groups of patients repeated infections are usually not associ-
ated with a detectable antibody response [75, 98]. Screening 
for RSV-specific antibodies is mostly performed to obtain 
seroepidemiologic information and for research purposes 
[99].  
FUTURE TRENDS AND NEEDS FOR IMPROVE-
MENT  
  Future developments for the diagnosis of viral respiratory 
tract infection should enhance the development of cost effec-
tive, sensitive and rapid tests allowing the screening of at 
risk populations for all probable causative agents. RT-
multiplex PCRs have been developed to use numerous prim-
ers within a single reaction tube to amplify nucleic acid 
fragments from different respiratory viral pathogens. Up to 
now data on the comparative analysis between multiplex 
reactions and mono-reactions on the same sample indicate a 
reduced sensitivity and specificity of the multiplex systems 
[80]. Therefore more research is needed to overcome the 
problems associated with the use of multiple sets of high 
concentration primers and to identify reaction conditions that 
can be combined in order to obtain maximal specificity with 
a minimal loss in sensitivity. Target-enriched multiplexing 
amplification and the use of padlock probe design may aid to 
overcome these technical problems [100]. In addition opti-
mized extraction procedures, improved standardisation asso-
ciated with more automation and different testing protocols 
for summer and winter months based on epidemiologic data 
will provide accurate and clinically meaningful results that 
will considerably improve diagnosis of respiratory infections 
and directly impact patient management.  
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